Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.

Holgersson G, Ekman S, Reizenstein J, Bergqvist M, Pontén F, Uhlén M, Magnusson K, Jonnalagadda P, Asplund A, Strömberg S, Linder A, Blomquist E, Liljeholm M, Lödén B, Hellström K, Bergström S.

Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):1-7.

PMID:
20181625
2.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
3.

Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.

Suwinski R, Jaworska M, Nikiel B, Grzegorz W, Bankowska-Wozniak M, Wojciech M, Krzysztof S, Dariusz L.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):438-46. doi: 10.1016/j.ijrobp.2009.05.021. Epub 2009 Sep 3.

PMID:
19733016
4.

Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy.

Kamijo T, Yokose T, Hasebe T, Yonou H, Sasaki S, Hayashi R, Ebihara S, Miyahara H, Hosoi H, Ochiai A.

Clin Cancer Res. 2000 Aug;6(8):3159-65.

5.

Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.

Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.

J Exp Clin Cancer Res. 2004 Jun;23(2):277-83.

PMID:
15354413
6.
7.

Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.

Bubb RS, Komaki R, Hachiya T, Milas I, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1216-24.

PMID:
12128123
8.

Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.

Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR.

J Surg Oncol. 2003 Jan;82(1):34-50.

PMID:
12501167
9.

Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.

Nguyen VN, Mirejovský P, Mirejovský T, Melínová L, Mandys V.

Acta Histochem. 2000 Aug;102(3):323-38.

PMID:
10990069
10.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

11.

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Ghosh N, Trivedi TI.

Ann Surg Oncol. 2000 May;7(4):305-11.

PMID:
10819372
12.

Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.

Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L.

Laryngoscope. 2000 Aug;110(8):1339-45.

PMID:
10942137
13.

p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.

Couture C, Raybaud-Diogène H, Têtu B, Bairati I, Murry D, Allard J, Fortin A.

Cancer. 2002 Feb 1;94(3):713-22.

14.

Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.

Lee BJ, Wang SG, Roh HJ, Goh EK, Chon KM, Park DY.

J Laryngol Otol. 2006 Jul;120(7):579-82. Epub 2006 May 4.

PMID:
16672091
15.

Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer.

Nagy B, Tiszlavicz L, Eller J, Molnar J, Thurzo L.

In Vivo. 2003 Jan-Feb;17(1):93-6.

PMID:
12655798
18.
19.

Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.

Samejima R, Kitajima Y, Yunotani S, Miyazaki K.

Anticancer Res. 1999 Nov-Dec;19(6C):5515-21.

PMID:
10697609
20.

Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.

Choi DH, Kim S, Rimm DL, Carter D, Haffty BG.

Cancer J. 2005 Sep-Oct;11(5):404-11.

PMID:
16259871

Supplemental Content

Support Center